Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedNo additions or deletions detected in the Study Details page for NCT03226678; core study information remains unchanged.SummaryDifference0.4%

- Check15 days agoNo Change Detected
- Check36 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

- Check44 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has been updated to include new facility and drug information, as well as specific publications related to pegcetacoplan treatment for autoimmune hemolytic anemia, while removing some location details and previous genetic resources.SummaryDifference6%

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.